文摘
Background The second-generation cryoballoon (CB-A) (Arctic Front Advance, Cryocath, Medtronic, MN, USA) might significantly improve procedural outcome with respect to the first-generation balloon. These technological improvements might also question the current recommendation of the need a 4-min freeze to achieve durable pulmonary vein isolation (PVI). Objective The main aim of the study was to analyze the procedural efficacy of a 3-min freeze–thaw cycles with the CB-A balloon in the terms of rates of acute PVI and 6-month outcome. Methods Patients having undergone CB-A for PAF or early persistent AF, with 3-min freeze–thaw cycles were consecutively included in our analysis. Acute procedural success was measured in terms of the rate of PVI. Short-term follow-up was evaluated by the means of 24-h Holters and clinical examinations at regular intervals. Results Fifty-two consecutive patients (35 male (67?%); mean age, 59.8?±-0.5) were included. Mean procedure and fluoroscopy times were 96?±-5 and 13.2?±-.3?min, respectively. Mean time from groin puncture to catheter extraction was 60.4?±-0?min. After a mean of 1.5 freeze cycles per vein of 3?min in duration, all 208 (100?%) PVs could be isolated with the CB-A. A total 192 (91?%) veins were isolated during the first freeze. At a mean of 5.7-month follow-up, 82?% of patients were free of AF. Conclusion CB-A is effective in producing PVI by using 3-min-duration freeze cycles. After a mean of 1.5 freeze per vein, freedom from AF was achieved in 82?% of patients at 6-month follow-up.